SAMPLE PREP

Following graduate school at the University of Kentucky College of Pharmacy, under the leadership of Professor Emeritus Dr. George Digenis, David began his career with 3M Pharmaceuticals in supporting preclinical toxicology studies and Phase I human clinical studies for the antiviral drug imiquimod (Aldara®). He also utilized pharmacokinetics to interpret data and wrote drug metabolism reports to support three investigational new drug (IND) submissions to the FDA... David next joined the 3M New Products Department where he was a global subject matter expert for a novel technology useful in analytical sample preparation. Using this technology, he developed Empore® High Performance Extraction Disk Cartridges and 96-Well Solid-Phase Extraction Plates for pharmaceutical bioanalytical laboratories, and supported applications development. Over an 8-year period he helped commercialize the Empore technology into a successful business and managed all technical service activities. The full..